ABOUT

We aim to build on the ‘known’ aspects of immunology to identify and develop therapies in areas of critical unmet need

OUR FOCUS

We aim to look at targets beyond PD1 and PDL1 in areas where the science matches the disease biology

CAPABILITIES

We have the translational infrastructure to rapidly develop proteins and small molecules to accelerate IND candidates

CONTACT US

Send message